Phase I study of alpha-tocopherlyoxyacetic acid in patients with advanced cancer

by Curti, Brendan D, Akporiaye, Emmanuel, Sutcliffe, Kim, Bahjat, Keith S, Koguchi, Yoshinobu, Cramer, Julie, Urba, Walter
Published 2015

Phase II calm extension study: Coxsackievirus A21 delivered intratumorally to patients with advanced melanoma induces immune-cell infiltration in the tumor microenvironment

by Andtbacka, Robert HI, Curti, Brendan D, Hallmeyer, Sigrun, Feng, Zipei, Paustian, Christopher, Bifulco, Carlo, Fox, Bernard, Grose, Mark, Shafren, Darren
Published 2015

Durable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy Program

by Payne, Roxanne, Glenn, Lyn, Hoen, Helena, Richards, Beverley, Smith, John W, Lufkin, Robert, Crocenzi, Todd S, Urba, Walter J, Curti, Brendan D
Published 2014

Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma

by Feng, Zipei, Puri, Sachin, Moudgil, Tarsem, Wood, William, Hoyt, Clifford C., Wang, Chichung, Urba, Walter J., Curti, Brendan D., Bifulco, Carlo B., Fox, Bernard A.
Published 2015

Serum immunoregulatory proteins as predictors of overall survival of metastatic melanoma patients treated with ipilimumab

by Koguchi, Yoshinobu, Hoen, Helena, Bambina, Shelly, Rynning, Michael, Fuerstenberg, Richard, Feng, Zipei, Fox, Bernard, Bifulco, Carlo, Curti, Brendan D, Urba, Walter, Milburn, Christina, Korman, Alan J, Bahjat, Keith S
Published 2015

An evaluation of autologous tumor-reactive TIL generation from head and neck squamous cell cancers

by Mougdil, Tarsem, Paustian, Christopher, Feng, Zipei, Leidner, Rom, Dubay, Christopher, Curti, Brendan D, Hu, Hong-Ming, Urba, Walter, Bifulco, Carlo, Fox, Bernard, Bell, Brian
Published 2015

Novel strategy to monitor apparent tumor-specific T cells in patients with cancer

by van de Ven, Rieneke, Hilton, Traci L, Dubay, Christopher J, Puri, Sachin, Hu, Hong-Ming, Leidner, Rom S, Bell, R Bryan, Urba, Walter J, Curti, Brendan D, Aung, Sandra, Fox, Bernard A
Published 2013

A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma

by Buchbinder, Elizabeth I., Gunturi, Anasuya, Perritt, Jessica, Dutcher, Janice, Aung, Sandra, Kaufman, Howard L., Ernstoff, Marc S., Miletello, Girald P., Curti, Brendan D., Daniels, Gregory A., Patel, Sapna P., Kirkwood, John M., Hallmeyer, Sigrun, Clark, Joseph I., Gonzalez, Rene, Richart, John M., Lutzky, Joe, Morse, Michael A., Sullivan, Ryan J., McDermott, David F.
Published 2016

Markers of inflammation are associated with clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab

by Sznol, Mario, Fishman, Mayer, Escudier, Bernard, McDermott, David F, Kluger, Harriet, Stadler, Walter M, Perez-Gracia, Jose, McNeel, Douglas G, Curti, Brendan D, Harrison, Michael R, Plimack, Elizabeth R, Appleman, Leonard, Fong, Lawrence, Drake, Charles G, Young, Tina C, Chasalow, Scott D, Ross-MacDonald, Petra, Simon, Jason S, Walker, Dana, Choueiri, Toni K
Published 2015

Adoptive TIL in HPV-negative oral scca

by Leidner, Rom, Curti, Brendan D, Payne, Roxanne M, Urba, Walter, Bahjat, Keith S, Koguchi, Yoshinobu, Nelson, Krista, Moore, Jennifer A, Crittenden, Marka, Ying, Yedeh, Patel, Ashish, Cheng, Allen, Bui, Tuan G, Hilton, Traci, Paustian, Christopher, Puri, Sachin, Hu, Hong Ming, Bifulco, Carlo, Feng, Zipei, Bell, R Bryan, Fox, Bernard
Published 2015